Alzheimer's Disease

Alzheimer's Disease Recent News

Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Exclusive: Longeveron Kickstarts Its Mid-Stage Alzheimer's Disease Trial